You are here

Article info

Article menu

Download PDFPDF

Research Article
FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab

Authors

  • Matthew Scarpelli Department of Medical PhysicsUniversity of Wisconsin 1111 Highland Ave 53792 Madison WI USA PubMed articlesGoogle scholar articles
  • Christopher Zahm University of Wisconsin Carbone Cancer Center 1111 Highland Ave 53792 Madison WI USA PubMed articlesGoogle scholar articles
  • Scott Perlman University of Wisconsin Carbone Cancer Center 1111 Highland Ave 53792 Madison WI USA Department of Radiology, Section of Nuclear MedicineUniversity of Wisconsin 600 Highland Avenue 53792 Madison WI USA PubMed articlesGoogle scholar articles
  • Douglas G. McNeel University of Wisconsin Carbone Cancer Center 1111 Highland Ave 53792 Madison WI USA Department of Medicine, Division of Hematology/OncologyUniversity of Wisconsin 600 Highland Avenue 53792 Madison WI USA PubMed articlesGoogle scholar articles
  • Robert Jeraj Department of Medical PhysicsUniversity of Wisconsin 1111 Highland Ave 53792 Madison WI USA University of Wisconsin Carbone Cancer Center 1111 Highland Ave 53792 Madison WI USA Department of Radiology, Section of Nuclear MedicineUniversity of Wisconsin 600 Highland Avenue 53792 Madison WI USA PubMed articlesGoogle scholar articles
  • Glenn Liu University of Wisconsin Carbone Cancer Center 1111 Highland Ave 53792 Madison WI USA Department of Medicine, Division of Hematology/OncologyUniversity of Wisconsin 600 Highland Avenue 53792 Madison WI USA PubMed articlesGoogle scholar articles
  1. ↵a matthewscarp{at}gmail.com
  2. ↵b cdzahm{at}gmail.com
  3. ↵c SPerlman{at}uwhealth.org
  4. ↵d dm3{at}medicine.wisc.edu
  5. ↵e rjeraj{at}wisc.edu
  6. ↵f gxl{at}medicine.wisc.edu
View Full Text

Citation

Scarpelli M, Zahm C, Perlman S, et al
FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab
Journal for ImmunoTherapy of Cancer 2019;7:23. doi: 10.1186/s40425-019-0516-1

Publication history

  • Received December 6, 2018
  • Accepted January 20, 2019
  • First published January 30, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.